Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rhythm Pharmaceuticals (RYTM) Net Cash Flow: 2015-2024

Historic Net Cash Flow for Rhythm Pharmaceuticals (RYTM) over the last 10 years, with Dec 2024 value amounting to $29.2 million.

  • Rhythm Pharmaceuticals' Net Cash Flow rose 26.31% to -$83.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.8 million, marking a year-over-year increase of 123.87%. This contributed to the annual value of $29.2 million for FY2024, which is 143.27% up from last year.
  • Per Rhythm Pharmaceuticals' latest filing, its Net Cash Flow stood at $29.2 million for FY2024, which was up 143.27% from -$67.5 million recorded in FY2023.
  • Rhythm Pharmaceuticals' Net Cash Flow's 5-year high stood at $68.4 million during FY2022, with a 5-year trough of -$67.5 million in FY2023.
  • Its 3-year average for Net Cash Flow is $10.1 million, with a median of $29.2 million in 2024.
  • Its Net Cash Flow has fluctuated over the past 5 years, first tumbled by 208.09% in 2021, then soared by 264.17% in 2022.
  • Over the past 5 years, Rhythm Pharmaceuticals' Net Cash Flow (Yearly) stood at $38.6 million in 2020, then crashed by 208.09% to -$41.7 million in 2021, then skyrocketed by 264.17% to $68.4 million in 2022, then plummeted by 198.58% to -$67.5 million in 2023, then soared by 143.27% to $29.2 million in 2024.